SATT AxLR
SATT AxLR
Governance
Services for companies
Annual reports
Assisting you
Researchers
Call-for-projects
Companies
Startups
Practical guide
Technology offerings
Invest
In our technologies
In our startups
Technologies
Startups
AxLR TV
Working with AxLR
Purchasing & public procurement
Join us
Our startups are hiring
Media
News
Agenda
Press kit
Communication kit
Contact
✕
Home
Available technology
AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancer
TARMAK
En savoir +
TARMAK
0
AVAILABLE TECHNOLOGY | Therapeutic combination – Synergy effect in pharmacology – Prostate cancer
INNOVAC PPR
En savoir +
INNOVAC PPR
0
AVAILABLE TECHNOLOGY | “Peste des Petits Ruminants” (PPR, sheep and goat plague) – Innovative vaccines – DIVA (“Differentiating Infected from Vaccinated Animals”)
MSC 2.0
En savoir +
MSC 2.0
1
AVAILABLE TECHNOLOGY | Myocardial infarction – Human mesenchymal stem cells – Innovative cell therapy
3D-CELLS
En savoir +
3D-CELLS
0
AVAILABLE TECHNOLOGY | Sub-micron fiber matrix – Electrospinning – 3D cell culture
PERSPECTYV
En savoir +
PERSPECTYV
0
AVAILABLE TECHNOLOGY | Facioscapulohumeral dystrophy – Personalized treatment –
RESIST-430
En savoir +
RESIST-430
0
AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Gamma-peptides
RESIST-655
En savoir +
RESIST-655
0
AVAILABLE TECHNOLOGY | Bacterial resistance to antibiotics – Gram-negative bacteria – Heterocyclic compounds
CAPDCM
En savoir +
CAPDCM
0
AVAILABLE TECHNOLOGY | Microfluidics – Chemoattraction – Drug release
PL-VAC
En savoir +
PL-VAC
0
AVAILABLE TECHNOLOGY | Leishmanioses – Secretomes – Multi-epitope peptide vaccine
Précédent
1
2
3
4
Suivant